Bass AS - Search Results

1

A Historical View and Vision into the Future of the Field of Safety Pharmacology.

Bass AS, Hombo T, Kasai C, Kinter LB, Valentin JP. Bass AS, et al. Handb Exp Pharmacol. 2015;229:3-45. doi: 10.1007/978-3-662-46943-9_1. Handb Exp Pharmacol. 2015. PMID: 26091634 Review.

2

Origins, practices and future of safety pharmacology.

Bass A, Kinter L, Williams P. Bass A, et al. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):145-51. doi: 10.1016/j.vascn.2004.02.007. J Pharmacol Toxicol Methods. 2004. PMID: 15172010 Review.

3

Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.

Bass AS, Vargas HM, Valentin JP, Kinter LB, Hammond T, Wallis R, Siegl PK, Yamamoto K. Bass AS, et al. J Pharmacol Toxicol Methods. 2011 Jul-Aug;64(1):7-15. doi: 10.1016/j.vascn.2011.05.006. Epub 2011 Jun 12. J Pharmacol Toxicol Methods. 2011. PMID: 21689769 Review.

4

International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes.

Bass AS, Darpo B, Breidenbach A, Bruse K, Feldman HS, Garnes D, Hammond T, Haverkamp W, January C, Koerner J, Lawrence C, Leishman D, Roden D, Valentin JP, Vos MA, Zhou YY, Karluss T, Sager P. Bass AS, et al. Br J Pharmacol. 2008 Aug;154(7):1491-501. doi: 10.1038/bjp.2008.279. Br J Pharmacol. 2008. PMID: 18663380 Free PMC article.

5

Points to consider emerging from a mini-workshop on cardiac safety: assessing torsades de pointes liability.

Bass A, Valentin JP, Fossa AA, Volders PG. Bass A, et al. J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):91-4. doi: 10.1016/j.vascn.2007.05.001. Epub 2007 May 24. J Pharmacol Toxicol Methods. 2007. PMID: 17707127

6

Introduction to nonclinical safety pharmacology and the safety pharmacology society.

Bass AS, Vargas HM, Kinter LB. Bass AS, et al. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):141-4. doi: 10.1016/j.vascn.2004.02.004. J Pharmacol Toxicol Methods. 2004. PMID: 15172009 No abstract available.

7

New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age.

Kinter LB, Siegl PK, Bass AS. Kinter LB, et al. Among authors: bass as. J Pharmacol Toxicol Methods. 2004 May-Jun;49(3):153-8. doi: 10.1016/j.vascn.2004.03.007. J Pharmacol Toxicol Methods. 2004. PMID: 15172011 Review. No abstract available.

8

Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A.

Valentin JP, Bass AS, Atrakchi A, Olejniczak K, Kannosuke F. Valentin JP, et al. Among authors: bass as. J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):22-9. doi: 10.1016/j.vascn.2005.04.009. J Pharmacol Toxicol Methods. 2005. PMID: 15961324 Review.

9

Drugs effects on ventricular repolarization: a critical evaluation of the strengths and weaknesses of current methodologies and regulatory practices.

Bass AS, Tomaselli G, Bullingham R 3rd, Kinter LB. Bass AS, et al. J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):12-21. doi: 10.1016/j.vascn.2005.04.010. J Pharmacol Toxicol Methods. 2005. PMID: 15967683 Review.

10

Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance.

Vargas HM, Bass AS, Koerner J, Matis-Mitchell S, Pugsley MK, Skinner M, Burnham M, Bridgland-Taylor M, Pettit S, Valentin JP. Vargas HM, et al. Among authors: bass as. Br J Pharmacol. 2015 Aug;172(16):4002-11. doi: 10.1111/bph.13207. Epub 2015 Jul 14. Br J Pharmacol. 2015. PMID: 26031452 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters